Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization

Figure 2 Representative cases for measurement of viable tumor size treated by TACE prior to LT. A: A tumor nodule with compact lipiodol uptake, no enhancement at arterial phase, and no washout at portal or delayed phase was considered as a non-viable tumor and was excluded from the measurement of tumor size or number; B: For a nodule showing arterial enhancement and delayed washout at the margin, tumor size was defined as the difference from diameter of the entire nodule to diameter of lipiodol-uptaken portion.